Stay updated on Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page.
Latest updates to the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedLocations now lists multiple state sites (Alabama, California, Georgia, Louisiana, Michigan, Minnesota, New York, Pennsylvania, Texas, Washington) with an updated Revision: v3.3.3. The HHS Vulnerability Disclosure link was removed.SummaryDifference0.8%
- Check28 days agoNo Change Detected
- Check49 days agoChange DetectedRevision: v3.3.2 was added and v3.2.0 was removed.SummaryDifference0.0%
- Check56 days agoChange DetectedRemoved the government funding status notice that was previously shown; the study details, contacts, and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check71 days agoChange DetectedThe study page details appear unchanged between the two screenshots; no additions or deletions to cohorts, eligibility criteria, or outcomes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check99 days agoChange DetectedUpdated page to v3.2.0, added government-status notice about potential delays, and removed a resource on Mature T-cell and NK-cell non-Hodgkin lymphoma.SummaryDifference3%
- Check107 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.1%
Stay in the know with updates to Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page.